TITLE

Keeping an eye on stem cells for studying disease modelling and cell-based therapy

AUTHOR(S)
Crombie, Duncan
PUB. DATE
March 2013
SOURCE
Australasian Biotechnology;Mar2013, Vol. 23 Issue 1, p19
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in treating eye-related diseases. Topics featured in the discussion include regenerative medicine, cell differentiation, and stem cell-based therapy. It mentions the Centre for Eye Research Australia which uses iPSCs and ESCs from individuals and patients with genetic diseases affecting the eye.
ACCESSION #
93831509

 

Related Articles

  • A Comparison of Stem Cells for Therapeutic Use. Rodgerson, Denis; Harris, Alan // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782 

    A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent...

  • Human stem cell research and regenerative medicine—present and future. Volarevic, Vladislav; Ljujic, Biljana; Stojkovic, Petra; Lukic, Aleksandra; Arsenijevic, Nebojsa; Stojkovic, Miodrag // British Medical Bulletin;Sep2011, Vol. 99 Issue 1, p155 

    Introduction Stem cells are cells with the ability to grow and differentiate into more than 200 cell types. Sources of data We review here the characteristics and potential of human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs). Areas of...

  • Stemming Our Irrational Exuberance. Brenner, Malcolm K. // Molecular Therapy;Aug2011, Vol. 19 Issue 8, p1399 

    The author reflects on the technique to generate human embryonic stem cells (hESCs) and inducible pluripotent stem cells (iPSCs). He says that hESCs and iPSCs are genetically modified and has a major benefit for almost every disease. An overview of the argument regarding the bond issue for the...

  • Senescence suppressors: their practical importance in replicative lifespan extension in stem cells. Hwang, Eun // Cellular & Molecular Life Sciences;Nov2014, Vol. 71 Issue 21, p4207 

    Recent animal and clinical studies report promising results for the therapeutic utilization of stem cells in regenerative medicine. Mesenchymal stem cells (MSCs), with their pluripotent nature, have advantages over embryonic stem cells in terms of their availability and feasibility. However,...

  • Personalized Regenerative Medicine. Arjmand, Babak; Goodarzi, Parisa; Mohamadi-Jahani, Fereshteh; Falahzadeh, Khadijeh; Larijani, Bagher // Acta Medica Iranica;2017, Vol. 55 Issue 3, p144 

    Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data. The terms precision and personalized medicines are sometimes...

  • The promise of induced pluripotent stem cells in research and therapy. Robinton, Daisy A.; Daley, George Q. // Nature;1/19/2012, Vol. 481 Issue 7381, p295 

    The field of stem-cell biology has been catapulted forward by the startling development of reprogramming technology. The ability to restore pluripotency to somatic cells through the ectopic co-expression of reprogramming factors has created powerful new opportunities for modelling human diseases...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Kriks, Sonja; Shim, Jae-Won; Piao, Jinghua; Ganat, Yosif M.; Wakeman, Dustin R.; Xie, Zhong; Carrillo-Reid, Luis; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Yang, Lichuan; Beal, M. Flint; Surmeier, D. James; Kordower, Jeffrey H.; Tabar, Viviane; Studer, Lorenz // Nature;12/22/2011, Vol. 480 Issue 7378, p547 

    Human pluripotent stem cells (PSCs) are a promising source of cells for applications in regenerative medicine. Directed differentiation of PSCs into specialized cells such as spinal motoneurons or midbrain dopamine (DA) neurons has been achieved. However, the effective use of PSCs for cell...

  • Strategies for enrichment and selection of stem cell-derived tissue precursors. Bernstein, Harold S.; Hyun, William C. // Stem Cell Research & Therapy;2012, Vol. 3 Issue 3, p1 

    Human embryonic stem cells have the capacity for self-renewal and pluripotency and thus are a primary candidate for tissue engineering and regenerative therapies. These cells also provide an opportunity to study the development of human tissues ex vivo. To date, numerous human embryonic stem...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics